Clinical trial

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

NCT01420250

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-09-22

PhasePHASE1

Study timeline

Study start (actual)2011-09-22Date precision: day

Registry last updated2025-05-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

CabazitaxelDRUG · verified · RxNorm: cabazitaxel

Intensity Modulated Radiation Therapy (IMRT)RADIATION

Anti-Androgen Therapy: BicalutamideDRUG

Luteinizing Hormone-Releasing Hormone (LHRH) AgonistGENETIC

Sponsors & collaborators

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson Universitylead sponsor

Sanoficollaborator

Mapped research locations

PhiladelphiaPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01420250 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.